<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-164596</identifier>
<setSpec>0034-0618</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Sepsis biomarkers: A review</dc:title>
<dc:description xml:lang="en">Infectious diseases, such as sepsis, are a serious health problem in the world, associated with high morbidity and mortality in all areas of health care. These are time dependent diseases in which the early application of diagnostic therapeutic actions, significantly improve patient survival and prognosis. To carry out this, we have tools such as biomarkers that help us in the diagnosis and prognosis of these pathologies; There are biomarkers widely used such as PCR, Procalcitonin or cytokines, and others that are less known as pro-adrenomedullin (pro-ADM), soluble triggering receptor expressed on myeloid cells-1 (sTREM-1), soluble urokinase-type plasminogen activator receptor (SuPAR), Pancreatic Stone Protein (PSP) or sCD25 (AU)</dc:description>
<dc:creator>García de Guadiana, Luis</dc:creator>
<dc:creator>Hernando Holgado, Ana</dc:creator>
<dc:creator>Albadalejo Otón, María Dolores</dc:creator>
<dc:creator>Fernández-Carballido, Ana</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Las enfermedades infecciosas, como la sepsis,  constituyen un grave problema de salud en el mundo, asociándose con una elevada morbilidad y mortalidad en todos los ámbitos de la asistencia sanitaria. Se trata de enfermedades tiempo dependientes en las que la aplicación precoz de una serie de medidas diagnostico terapéuticas mejoran de forma significativa la supervivencia y el pronóstico del paciente. Para ello se disponen de herramientas como los biomarcadores que nos ayudan tanto en el diagnóstico como pronóstico de estas patologías; biomarcadores clásicos y ampliamente utilizados como la PCR, procalcitonina o citocinas y otros menos conocidos como presepsina, pro-adrenomedulina (pro-ADM), soluble triggering receptor expressed on myeloid cells-1 (sTREM-1), soluble urokinase-type plasminogen activator receptor (suPAR), Pancreatic Stone Protein (PSP) o sCD25 (AU)</dc:description>
<dc:source>An Real Acad Farm;83(2): 175-187, 2017. graf, tab, ilus</dc:source>
<dc:identifier>ibc-164596</dc:identifier>
<dc:title xml:lang="es">Biomarcadores empleados en sepsis</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d22124^s22002</dc:subject>
<dc:subject>^d7414^s22032</dc:subject>
<dc:subject>^d23568^s22002</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d24549^s22002</dc:subject>
<dc:subject>^d52207^s22002</dc:subject>
<dc:subject>^d32031^s22032</dc:subject>
<dc:subject>^d29310</dc:subject>
<dc:subject>^d28903^s22002</dc:subject>
<dc:type>article</dc:type>
<dc:date>201700</dc:date>
</metadata>
</record>
</ibecs-document>
